SignalCorporate
Hansa Biopharma GAAP EPS of -$1.75, revenue of $143M
Hansa Biopharma reported GAAP EPS of -$1.75 and revenue of $143M.
Context
What happened: Hansa Biopharma reported third quarter GAAP EPS of -SEK1.75 and revenue of SEK143M.
Key numbers: Q3 GAAP EPS -SEK1.75. Revenue SEK143M, up 364.3% Y/Y from SEK30.8M in the prior year period.
Why it matters: The revenue increase was primarily driven by revenue recognized under the license agreement with SERB Pharmaceuticals.
Coverage: 6 outlets in 24h
What changed
Hansa Biopharma reported third quarter GAAP EPS of -SEK1.75 and revenue of SEK143M.
Why it matters
The revenue increase was primarily driven by revenue recognized under the license agreement with SERB Pharmaceuticals.